loading
Mural Oncology Plc stock is traded at $2.32, with a volume of 197.65K. It is up +3.11% in the last 24 hours and down -7.20% over the past month. Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.
See More
Previous Close:
$2.25
Open:
$2.29
24h Volume:
197.65K
Relative Volume:
1.40
Market Cap:
$40.06M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-4.25%
1M Performance:
-7.20%
6M Performance:
-38.13%
1Y Performance:
-33.33%
1-Day Range:
Value
$2.28
$2.40
1-Week Range:
Value
$2.18
$2.45
52-Week Range:
Value
$0.95
$4.74

Mural Oncology Plc Stock (MURA) Company Profile

Name
Name
Mural Oncology Plc
Name
Phone
353 1 905 8020
Name
Address
10 EARLSFORT TERRACE, DUBLIN 2
Name
Employee
116
Name
Twitter
Name
Next Earnings Date
2025-05-20
Name
Latest SEC Filings
Name
MURA's Discussions on Twitter

Compare MURA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
MURA
Mural Oncology Plc
2.32 38.85M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
462.13 117.32B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.87 58.89B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
401.80 51.14B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
673.80 41.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
299.01 32.59B 3.81B -644.79M -669.77M -6.24

Mural Oncology Plc Stock (MURA) Upgrades & Downgrades

Date Action Analyst Rating Change
Mar-25-25 Downgrade Morgan Stanley Overweight → Equal-Weight
Mar-25-25 Downgrade Raymond James Strong Buy → Outperform
Jun-28-24 Initiated Rodman & Renshaw Buy
Apr-04-24 Initiated Morgan Stanley Overweight

Mural Oncology Plc Stock (MURA) Latest News

pulisher
Aug 01, 2025

How volatile is Mural Oncology plc stock compared to the marketEarnings Report Alerts To Watch Now - jammulinksnews.com

Aug 01, 2025
pulisher
Aug 01, 2025

Form 8.3Mural Oncology plc - Business Wire

Aug 01, 2025
pulisher
Jul 31, 2025

How strong is Mural Oncology plc company’s balance sheetExpert Picks Ideas For Smart Trading - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 30, 2025

Mural Oncology plc Forms Bullish Flag — Upside AheadDaily Stock Market Swing Alerts Highlight Key Movers - beatles.ru

Jul 30, 2025
pulisher
Jul 29, 2025

Is Mural Oncology plc the Top Chart Pick This WeekAlpha Focused Technical Trade Signals Gain Attention - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Can Mural Oncology plc Regain Lost Ground This QuarterTechnical Stock Breakout Predictions Signal Entry Points - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Support Zone Holds Steady for Mural Oncology plc After DipShort Term Trading Opportunity Watch Sees Shift - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Mural Oncology plc Price Targets Raised After ReboundTrade Timing Strategy With Technical Data Explained - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Mural Oncology plc Attempts Reversal From Key SupportCommunity Verified Stock Suggestions Drive Volume - metal.it

Jul 29, 2025
pulisher
Jul 28, 2025

What makes Mural Oncology plc stock price move sharplyStock Market Data Feed For Consistent Profits - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Watch for Trend Continuation in Mural Oncology plc Next WeekStock Selection With High Accuracy Based on Models - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Real Time Chart Alerts Flash Bullish on Mural Oncology plcCapital Preserving Trade Plan Templates Shared - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Should I hold or sell Mural Oncology plc stock in 2025Unlock your portfolio’s full growth potential - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Mural Oncology plc Pullback Analyzed — Is It Time to ExitOversold Bounce Stock Play Ideas Gain Attention - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

How Resilient Is Mural Oncology plc Stock During Economic DownturnsTop Performing Low Risk Stocks - metal.it

Jul 28, 2025
pulisher
Jul 27, 2025

What are analysts’ price targets for Mural Oncology plc in the next 12 monthsDiscover stocks with explosive potential - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 25, 2025

Mural Oncology plc Stock Analysis and ForecastOutstanding investment returns - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Is Mural Oncology plc a good long term investmentUnmatched market gains - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Will Mural Oncology plc stock benefit from interest rate changesBreakthrough profit margins - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about Mural Oncology plc stockFastest return on investment - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Is Mural Oncology plc stock a growth or value playBreakneck growth rates - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 22, 2025

What drives Mural Oncology plc stock priceHigh-yield investments - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Why Mural Oncology plc stock attracts strong analyst attentionReturn Maximized Portfolio Strategy - Newser

Jul 22, 2025
pulisher
Jul 21, 2025

Can Mural Oncology (NASDAQ:MURA) Afford To Invest In Growth? - Yahoo Finance

Jul 21, 2025

Mural Oncology Plc Stock (MURA) Financials Data

There is no financial data for Mural Oncology Plc (MURA). Check out other stocks for more information.

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Mural Oncology Plc Stock (MURA) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Keson-Brookes Maiken
See Remarks
Jul 18 '25
Sale
2.48
2,158
5,352
71,406
$75.59
price up icon 0.93%
$37.11
price up icon 0.84%
$108.69
price up icon 1.31%
$27.07
price up icon 2.65%
$107.34
price down icon 0.15%
biotechnology ONC
$299.01
price down icon 0.70%
Cap:     |  Volume (24h):